Research

Our highlighted selection of recent Covid-related case series or case reports from the scientific press for January 2023.

Our pick of COVID-19-related cross-sectional case control studies from the scientific press for January 2023.

Our paper of the month reports the results of the ENCHANTED 2/MT trial, performed in 44 Chinese hospitals to compare more intensive with less intensive blood pressure management after successful endovascular thrombectomy.

Our authors of the month compared the occurrence of stroke, utilisation of recanalisation procedures, and demographic parameters during the pandemic period with data from the preceding year.

This recent EAN-funded study investigates the prevalence of burnout profiles and their contributing factors in European neurology residents, junior neurologists, and research fellows.

Our highlighted selection of COVID-19-related meta-analyses and systemic reviews from the scientific press for December 2022.

Our pick of COVID-19-related cross-sectional case control studies from the scientific press for December 2022.

In order to support and develop expertise in bridging the gap between neuroscience and clinical knowledge the EAN Board has created a Scientific Panel on Neuroscience/Translational Neurology.

Our authors of the month report the results of a multicentre phase-3 clinical trial exploring efficacy and safety of Lecanemab in patients with early AD over a follow-up period of eighteen months.

Our authors of the month conducted a retrospective study of the potential association between COVID-19 and seizures or epilepsy in the six months after infection, using an electronic health records network of 81 million people.

A new publication in the European Journal of Neurology describes the process of developing and launching the EAN guideline prioritisation procedure.

EAN Guideline production group (GPG) reports from this year's Guidelines International Network conference in Toronto.

Our research paper of the month presents the results of the Endovascular Treatment for Acute Basilar-Artery Occlusion (ATTENTION) trial; a multicentre, prospective, randomised and open-label trial, conducted in 36 Chinese centres.

The authors of our Covid paper of the month conducted this cross sectional study in southern Germany involving people aged 18–65, confirming the existence of a considerable burden of self-reported post-acute symptom clusters

The EAN is pleased to announce we are developing the EAN Strategic Research Agenda to address current gaps and set priority areas for new clinically relevant research.